Pilkington, Karen and CAM-Cancer Consortium, . (2012) CAM Summary: Echinacea spp. Concerted action for complementary and alternative medicine assessment in the cancer field (CAM-Cancer) project. Project Report. CAM-Cancer Consortium (Complementary and Alternative Medicine for Cancer).
Full text not available from this repository.
Official URL: http://www.cam-cancer.org/CAM-Summaries/Herbal-pro...
Echinacea (coneflower) products are herbal preparations derived from the root and above ground parts of the flowering plants Echinacea purpurea, Echinacea pallida and Echinacea angustifolia. Echinacea has a long history of medicinal use and is widely used in the treatment and prevention of upper respiratory tract infections. Claims in relation to cancer are that it can boost the immune system, reduce the adverse effects of chemotherapy and radiotherapy and has some anticancer effects. In vitro studies have suggested immunostimulating and anti-cancer activity of various constituents of echinacea. However, clinical studies investigating these effects have been limited by small sample sizes, lack of a control group or use of combination products. Echinacea is generally well-tolerated with the most frequently reported adverse effects being gastrointestinal upsets and rashes. Theoretically, echinacea may interact with immunosuppressive drugs and with metabolism of drugs via the cytochrome P450 system. In summary, there is currently insufficient evidence to support or refute the claims for echinacea in relation to cancer management.
|Item Type:||Monograph (Project Report)|
|Research Community:||University of Westminster > Life Sciences, School of|
|Deposited On:||24 Oct 2012 10:35|
|Last Modified:||24 Oct 2012 11:01|
Repository Staff Only: item control page